DK2256495T3 - System til overvågning af fysiske karakteristika ifølge en brugers biologiske tilstand - Google Patents

System til overvågning af fysiske karakteristika ifølge en brugers biologiske tilstand Download PDF

Info

Publication number
DK2256495T3
DK2256495T3 DK10178254.8T DK10178254T DK2256495T3 DK 2256495 T3 DK2256495 T3 DK 2256495T3 DK 10178254 T DK10178254 T DK 10178254T DK 2256495 T3 DK2256495 T3 DK 2256495T3
Authority
DK
Denmark
Prior art keywords
alarm
user
glucose
monitor
sensor
Prior art date
Application number
DK10178254.8T
Other languages
English (en)
Inventor
Frank Saidara
John J Mastrototaro
Charles Vallet Tolle
John C Mueller Jr
Jeff B Sanders
Edward S Nielsen
Original Assignee
Medtronic Minimed Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37684661&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2256495(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US10/860,114 external-priority patent/US7399277B2/en
Application filed by Medtronic Minimed Inc filed Critical Medtronic Minimed Inc
Application granted granted Critical
Publication of DK2256495T3 publication Critical patent/DK2256495T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/1495—Calibrating or testing of in-vivo probes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7271—Specific aspects of physiological measurement analysis
    • A61B5/7275—Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/48785—Electrical and electronic details of measuring devices for physical analysis of liquid biological material not specific to a particular test method, e.g. user interface or power supply
    • G01N33/48792—Data management, e.g. communication with processing unit
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/63—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2560/00—Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
    • A61B2560/02—Operational features
    • A61B2560/0242—Operational features adapted to measure environmental factors, e.g. temperature, pollution
    • A61B2560/0247—Operational features adapted to measure environmental factors, e.g. temperature, pollution for compensation or correction of the measured physiological value
    • A61B2560/0252—Operational features adapted to measure environmental factors, e.g. temperature, pollution for compensation or correction of the measured physiological value using ambient temperature
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2560/00—Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
    • A61B2560/04—Constructional details of apparatus
    • A61B2560/0443—Modular apparatus
    • A61B2560/045—Modular apparatus with a separable interface unit, e.g. for communication
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14542—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring blood gases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/1468—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/1486—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using enzyme electrodes, e.g. with immobilised oxidase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7271—Specific aspects of physiological measurement analysis
    • A61B5/7282—Event detection, e.g. detecting unique waveforms indicative of a medical condition
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/74—Details of notification to user or communication with user or patient ; user input means
    • A61B5/746—Alarms related to a physiological condition, e.g. details of setting alarm thresholds or avoiding false alarms

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medical Informatics (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Optics & Photonics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Primary Health Care (AREA)
  • Epidemiology (AREA)
  • Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Databases & Information Systems (AREA)
  • Veterinary Medicine (AREA)
  • Data Mining & Analysis (AREA)
  • Chemical & Material Sciences (AREA)
  • Business, Economics & Management (AREA)
  • Urology & Nephrology (AREA)
  • Signal Processing (AREA)
  • Psychiatry (AREA)
  • Emergency Medicine (AREA)
  • Physiology (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Human Computer Interaction (AREA)
  • Hematology (AREA)
  • General Business, Economics & Management (AREA)
  • Artificial Intelligence (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)

Claims (14)

1. Apparat (100) omfattende: en sensorindgang (106), som er i stand til at modtage i det mindste et signal fra en sensor (102), idet signalet er baseret på et antal affølte fysiologiske karakteristiske værdier ved en bruger af apparatet, hvorved antallet af affølte fysiologiske karakteristiske værdier omfatter: blodglucosekoncentrationer i brugeren, og hastigheden, hvorved blodglucosekoncentrationerne i brugeren ændrer sig over en forudbestemt tidsperiode, en processor (108), som er koblet til sensorindgangen (106) til drivning af et antal alarmer, som er baseret på det modtagne signal fra sensoren, hvorved processoren er i stand til at aktivere hver alarm ud af antallet af alarmer en forskellig affølt fysiologisk karakteristisk værdi ud af antallet af affølte fysiologiske karakteristiske værdier, og kendetegnet ved, en alarmslumrefunktion, som: tillader brugeren at ignorere en første alarm i en forudbestemt periode, hvorved den første alarm aktiveres i en første fysiologisk karakteristisk værdi, og ikke tillader brugeren at ignorere en anden alarm, som aktiveres af en anden fysiologisk karakteristisk værdi.
2. Apparat ifølge krav 1, og som yderligere omfatter en alarmgentagelsesforsinkelsesfunktion, som aktiveres som svar på den første alarm og forsinker gentagelsen af alarmen i en forudbestemt tidsperiode efter en måling af koncentrationen af blodglucose først indikerer en glykæmisk tilstand.
3. Apparat ifølge krav 1, hvorved en første alarm aktiveres, når glucosekoncen-trationer udviser en forudbestemt ændringshastighed, og en anden alarm aktiveres, når glucosekoncentrationerne når en forudbestemt værdi.
4. Apparat ifølge krav 3, hvorved kriteriet for aktivering af den første alarm er mere stringent end kriteriet for aktivering af den anden alarm.
5. Apparat ifølge krav 3, hvorved processoren er i stand til at aktivere en alarm baseret på en evaluering af både glodglucosekoncentrationerne og hastigheden af ændringen af blodglucosekoncentrationer.
6. Apparat ifølge krav 5, hvorved alarmen aktiveres baseret på en matematisk sammenligning af blodglucosekoncentrationerne i brugeren og hastigheden af ændringen af blodglucosekoncentrationer i brugeren.
7. Apparat ifølge krav 1, og som yderligere omfatter et relæ, som automatisk opkalder et forudbestemt telefonnummer som en del af en notifikationsordning for en begivenhed, som ikke er blevet bekræftet og/eller adresseret af brugeren.
8. Apparat ifølge krav 1, hvorved den første og anden fysiologiske karakteristiske værdi omfatter hypoglykæmi eller hyperglykæmi, og hvorved den første og anden alarm er indstillet forskellig for hypoglykæmiske alarmer eller hypoglykæmiske alarmer af forskellig alvorlighed.
9. Apparat ifølge krav 8, hvorved den første og anden alarm er hyperglykæmi-ske alarmer, og den første alarm trigges ved hjælp af en lavere hyperglykæmisk tærskelværdi og den anden alarm trigges ved hjælp af en højere hyperglykæmisk tærskelværdi.
10. Apparat ifølge krav 1, hvorved: den første alarm er baseret på en detektionsordning for fysiologiske glucose-niveauer, som når en forudbestemt tærskelkoncentration, og den anden alarm er baseret på en detektionsordning for en specifik hastighed, ved hvilken fysiologiske glucoseniveauer ændres i brugeren.
11. Apparat ifølge krav 1, hvorved: den første alarm er baseret på en detektionsordning for en specifik hastighed, ved hvilken fysiologiske glucoseniveauer ændrer sig i brugeren, og den anden alarm er baseret på en detektionsordning for fysiologiske glucoseniveauer, som når en forudbestemt tærskelkoncentration.
12. Apparat ifølge krav 1, hvorved alarmslumrefunktionen igangsættes af brugeren og forhindrer den første alarm i at blive igangsat i en specifik tidsperiode, som er valgt af brugeren ud fra en liste af slumreperiodetilvækster.
13. Apparat ifølge krav 12, hvorved apparatet omfatter en displayskærm, og brugeren kan rulle igennem en liste af forsinkelsestilvækster og udvælge den specifikke tidsperiode ud fra en liste af forsinkelsestilvækster.
14. Apparat ifølge ethvert af kravene 1-13, hvorved en tidsmåler igangsættes, når et første interval af affølte fysiologiske karakteristiske værdier overskrides, hvorved udløb forårsager påmindelser af den første alarm, hvis i mellemtiden et andet interval af den affølte værdi ikke er blevet overskredet, og hvis det andet interval (504) overskrides inden for en tidsperiode, den anden alarm udsendes og tidsmåleren genstartes, uden at der udsendes nogen påmindelse ved udløbet af den første tidsperiode, hvorved en påmindelse udsendes ved udløbet af en anden tidsmåler.
DK10178254.8T 2004-06-03 2005-05-20 System til overvågning af fysiske karakteristika ifølge en brugers biologiske tilstand DK2256495T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/860,114 US7399277B2 (en) 2001-12-27 2004-06-03 System for monitoring physiological characteristics
EP05755120A EP1759201B1 (en) 2004-06-03 2005-05-20 System for monitoring physiological characteristics according to the user biological state

Publications (1)

Publication Number Publication Date
DK2256495T3 true DK2256495T3 (da) 2015-11-09

Family

ID=37684661

Family Applications (3)

Application Number Title Priority Date Filing Date
DK10178254.8T DK2256495T3 (da) 2004-06-03 2005-05-20 System til overvågning af fysiske karakteristika ifølge en brugers biologiske tilstand
DK10178251.4T DK2259057T3 (da) 2004-06-03 2005-05-20 System til overvågning af fysiske karakteristika alt efter brugerens fysiske tilstand
DK10177011.3T DK2256494T3 (da) 2004-06-03 2005-05-20 System til overvågning af fysiologiske karakteristika alt efter brugerens biologiske tilstand

Family Applications After (2)

Application Number Title Priority Date Filing Date
DK10178251.4T DK2259057T3 (da) 2004-06-03 2005-05-20 System til overvågning af fysiske karakteristika alt efter brugerens fysiske tilstand
DK10177011.3T DK2256494T3 (da) 2004-06-03 2005-05-20 System til overvågning af fysiologiske karakteristika alt efter brugerens biologiske tilstand

Country Status (6)

Country Link
EP (4) EP2259057B1 (da)
JP (1) JP5594935B2 (da)
AT (1) ATE484745T1 (da)
CA (1) CA2816310C (da)
DE (1) DE602005024133D1 (da)
DK (3) DK2256495T3 (da)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7647202B2 (en) * 2006-07-05 2010-01-12 Arizona Public Service Company Method for exception-based notification of the condition of an apparatus
JP4800373B2 (ja) 2007-12-12 2011-10-26 パナソニック株式会社 生体試料測定装置
IL197532A0 (en) * 2008-03-21 2009-12-24 Lifescan Scotland Ltd Analyte testing method and system
JP2009244006A (ja) * 2008-03-31 2009-10-22 Dkk Toa Corp イオン濃度の変化量を示す測定装置
DK3718922T3 (da) * 2009-08-31 2022-04-19 Abbott Diabetes Care Inc Glucoseovervågningssystem og fremgangsmåde
RU2012112589A (ru) * 2009-09-02 2013-10-10 Юниверсити Оф Вирджиния Пэйтент Фаундейшн Отслеживание вероятности приближающейся гипогликемии при диабете на основе данных самостоятельного контроля глюкозы в крови
CA2957595C (en) * 2009-09-29 2020-06-02 Lifescan Scotland Limited Analyte testing method and device for diabetes management
JP5909037B2 (ja) 2009-10-07 2016-04-26 日本光電工業株式会社 アラーム優先度の変更機能付き生体情報モニタ装置及びアラーム制御方法
JP5083297B2 (ja) * 2009-11-18 2012-11-28 セイコーエプソン株式会社 予測血糖値算出装置、予測血糖値算出方法およびプログラム
US9563743B2 (en) * 2010-02-25 2017-02-07 Lifescan Scotland Limited Analyte testing method and system with high and low blood glucose trends notification
BR112012024813A8 (pt) * 2010-03-31 2017-10-17 Animas Corp método e sistema para mostrar dados de sensor de analito
US20120130646A1 (en) * 2010-11-19 2012-05-24 Lifescan, Inc. Analyte testing method and system with high and low analyte trends notification
US9033877B2 (en) * 2011-02-23 2015-05-19 Roche Diabetes Care, Inc. Device and method for determining blood glucose characteristics
MX346058B (es) * 2011-04-14 2017-03-06 Koninklijke Philips Nv Metodo de alarma gradual para monitores de pacientes.
JP5653469B2 (ja) * 2012-03-30 2015-01-14 アークレイ株式会社 測定装置および測定システム
US9119529B2 (en) * 2012-10-30 2015-09-01 Dexcom, Inc. Systems and methods for dynamically and intelligently monitoring a host's glycemic condition after an alert is triggered
WO2014093021A1 (en) * 2012-12-12 2014-06-19 Edwards Lifesciences Corporation System for controlling presentation of an estimated analyte value
US9636070B2 (en) 2013-03-14 2017-05-02 DePuy Synthes Products, Inc. Methods, systems, and devices for monitoring and displaying medical parameters for a patient
RU2673076C2 (ru) * 2013-06-13 2018-11-22 Ф.Хоффманн-Ля Рош Аг Способ и аппарат для мониторирования характеристик в сочетании с режимом непрерывного измерения уровня гликемии и компьютерный программный продукт
EP2851824A1 (en) 2013-09-20 2015-03-25 Sanofi-Aventis Deutschland GmbH Data management unit for supporting health control
EP2851823A1 (en) 2013-09-20 2015-03-25 Sanofi-Aventis Deutschland GmbH Data management unit for supporting health control
EP3063686A2 (en) * 2013-10-31 2016-09-07 Dexcom, Inc. Adaptive interface for continuous monitoring devices
AU2015302025B2 (en) * 2014-08-11 2021-08-19 The Regents Of The University Of California Continuous analyte sensor
DK3210137T3 (da) * 2014-10-22 2021-04-06 Dexcom Inc Brugergrænseflader til kontinuerlig glukosemonitorering
JP6622478B2 (ja) * 2015-03-31 2019-12-18 日本光電工業株式会社 医療機器、及び医療システム
JP6685664B2 (ja) * 2015-07-10 2020-04-22 パラマウントベッド株式会社 患者状態通報装置、患者状態通報システム及び患者状態通報装置における通報方法
US10413254B2 (en) 2016-07-08 2019-09-17 General Electric Company Dynamic automated adjustment of alarm threshold levels
US9852265B1 (en) * 2016-09-30 2017-12-26 General Electric Company System and method of medical device alarm management
CA3099113A1 (en) 2018-05-04 2019-11-07 Insulet Corporation Safety constraints for a control algorithm-based drug delivery system
US10720029B1 (en) 2019-02-05 2020-07-21 Roche Diabetes Care, Inc. Medical device alert, optimization, personalization, and escalation
CN114026653A (zh) * 2019-06-27 2022-02-08 伊莱利利公司 用于检测遗漏的推注剂量的系统和方法
CN112444634A (zh) * 2019-08-30 2021-03-05 深圳迈瑞生物医疗电子股份有限公司 一种样本分析装置及其报警方法
GB2607265A (en) * 2021-03-31 2022-12-07 The Flame Lily Holdings Ltd Outputting a notification

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4573994A (en) 1979-04-27 1986-03-04 The Johns Hopkins University Refillable medication infusion apparatus
US4678408A (en) 1984-01-06 1987-07-07 Pacesetter Infusion, Ltd. Solenoid drive apparatus for an external infusion pump
US4685903A (en) 1984-01-06 1987-08-11 Pacesetter Infusion, Ltd. External infusion pump apparatus
US4562751A (en) 1984-01-06 1986-01-07 Nason Clyde K Solenoid drive apparatus for an external infusion pump
US5299571A (en) 1993-01-22 1994-04-05 Eli Lilly And Company Apparatus and method for implantation of sensors
US5497772A (en) 1993-11-19 1996-03-12 Alfred E. Mann Foundation For Scientific Research Glucose monitoring system
US5391250A (en) 1994-03-15 1995-02-21 Minimed Inc. Method of fabricating thin film sensors
US5390671A (en) 1994-03-15 1995-02-21 Minimed Inc. Transcutaneous sensor insertion set
US5482473A (en) 1994-05-09 1996-01-09 Minimed Inc. Flex circuit connector
US5586553A (en) 1995-02-16 1996-12-24 Minimed Inc. Transcutaneous sensor insertion set
US6558351B1 (en) 1999-06-03 2003-05-06 Medtronic Minimed, Inc. Closed loop system for controlling insulin infusion
US6579690B1 (en) * 1997-12-05 2003-06-17 Therasense, Inc. Blood analyte monitoring through subcutaneous measurement
US7647237B2 (en) 1998-04-29 2010-01-12 Minimed, Inc. Communication station and software for interfacing with an infusion pump, analyte monitor, analyte meter, or the like
US6175752B1 (en) 1998-04-30 2001-01-16 Therasense, Inc. Analyte monitoring device and methods of use
US6558320B1 (en) 2000-01-20 2003-05-06 Medtronic Minimed, Inc. Handheld personal data assistant (PDA) with a medical device and method of using the same
US6554798B1 (en) 1998-08-18 2003-04-29 Medtronic Minimed, Inc. External infusion device with remote programming, bolus estimator and/or vibration alarm capabilities
JP4469504B2 (ja) 1998-10-08 2010-05-26 メドトロニック ミニメド インコーポレイテッド 遠隔形質モニタシステム
US6895263B2 (en) 2000-02-23 2005-05-17 Medtronic Minimed, Inc. Real time self-adjusting calibration algorithm
FI115289B (fi) * 2000-02-23 2005-04-15 Polar Electro Oy Elimistön energia-aineenvaihdunnan ja glukoosin määrän mittaaminen
JP2003533318A (ja) * 2000-05-25 2003-11-11 ヘルセテック インコーポレイテッド 手首に取りつけられた装置を用いる生理的な監視
JP2004515000A (ja) * 2000-10-27 2004-05-20 ディジタル・エンジェル・コーポレーション 監視追跡システム及び方法
AU2002312577A1 (en) * 2001-06-22 2003-01-08 Ronald D. Sekura Prescription compliance device and method of using device
US20030208113A1 (en) * 2001-07-18 2003-11-06 Mault James R Closed loop glycemic index system
JP3538399B2 (ja) * 2001-08-21 2004-06-14 コーリンメディカルテクノロジー株式会社 患者監視装置
US20030175806A1 (en) 2001-11-21 2003-09-18 Peter Rule Method and apparatus for improving the accuracy of alternative site analyte concentration measurements
US7022072B2 (en) * 2001-12-27 2006-04-04 Medtronic Minimed, Inc. System for monitoring physiological characteristics
US20050027182A1 (en) * 2001-12-27 2005-02-03 Uzair Siddiqui System for monitoring physiological characteristics
JP3872371B2 (ja) * 2002-03-29 2007-01-24 セイコーインスツル株式会社 携帯型生体情報収集装置、生体情報収集システム及び生体情報収集方法
US7278983B2 (en) 2002-07-24 2007-10-09 Medtronic Minimed, Inc. Physiological monitoring device for controlling a medication infusion device
US20040068230A1 (en) 2002-07-24 2004-04-08 Medtronic Minimed, Inc. System for providing blood glucose measurements to an infusion device
US9921703B2 (en) 2012-11-27 2018-03-20 Guardian Glass, LLC Transparent conductive coating for capacitive touch panel with additional functional film(s)
US9496283B1 (en) 2015-08-10 2016-11-15 Stmicroelectronics, Inc. Transistor with self-aligned source and drain contacts and method of making same

Also Published As

Publication number Publication date
EP2259057B1 (en) 2016-01-27
DK2256494T3 (da) 2017-04-10
ATE484745T1 (de) 2010-10-15
EP2259057A1 (en) 2010-12-08
DK2259057T3 (da) 2016-05-09
EP1759201A2 (en) 2007-03-07
JP5594935B2 (ja) 2014-09-24
EP2256495A2 (en) 2010-12-01
JP2008501426A (ja) 2008-01-24
EP2256494A1 (en) 2010-12-01
DE602005024133D1 (de) 2010-11-25
CA2816310A1 (en) 2005-12-22
CA2816310C (en) 2016-09-06
EP2256494B1 (en) 2017-01-11
EP2256495B1 (en) 2015-07-29
EP2256495A3 (en) 2011-03-23
EP1759201B1 (en) 2010-10-13

Similar Documents

Publication Publication Date Title
DK2256495T3 (da) System til overvågning af fysiske karakteristika ifølge en brugers biologiske tilstand
US7399277B2 (en) System for monitoring physiological characteristics
US20080255438A1 (en) System for monitoring physiological characteristics
CA2550855C (en) System for monitoring physiological characteristics
US7022072B2 (en) System for monitoring physiological characteristics
US10080529B2 (en) System for monitoring physiological characteristics
US10448834B2 (en) Smart messages and alerts for an infusion delivery and management system
EP2862586B1 (en) Control unit for infusion pump units, including a controlled intervention unit
CA2567711C (en) System for monitoring physiological characteristics